Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2011-04-12
2011-04-12
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C544S140000, C514S236500, C514S237500, C514S326000, C548S365100, C546S211000
Reexamination Certificate
active
07923004
ABSTRACT:
Aryl substituted pyrazole derivatives are provided, as well as processes for their preparation. The invention also provides compositions and methods for the treatment of HCV by administering a compound of the present invention, alone or in combination with additional antiviral agents, in a therapeutically effective amount.
REFERENCES:
patent: 5091386 (1992-02-01), Kesseler et al.
patent: 5300521 (1994-04-01), Eberle et al.
patent: 6916839 (2005-07-01), Ebenbeck et al.
patent: 7238722 (2007-07-01), Ebenbeck et al.
patent: 2002/0156115 (2002-10-01), Oda et al.
patent: 2002/0183366 (2002-12-01), Garvey et al.
patent: 2003/0191171 (2003-10-01), Oda et al.
patent: 2006/0183751 (2006-08-01), Hu et al.
patent: 1 219 173 (2002-07-01), None
patent: WO 02/051810 (2002-07-01), None
patent: WO 2005/033100 (2005-04-01), None
patent: WO 2006/028524 (2006-03-01), None
Chen et al. Bioorg. Med. Chem. Lett. 19 (2009) 1105-1109.
“Apath, LLC: HCV Replicon,” 2003, [Online] [Retrieved on Nov. 15, 2007] Retrieved from the Internet<URL:http://www.apath.com/Directory/Licensing/Technology/HCV—Replicon.asp>.
Chawla, G. et al., “Challenges in Polymorphism of Pharmaceuticals,” CRIPS, Jan.-Mar. 2004, pp. 9-12, vol. 5, No. 1.
“Hepatitis C: Treatment—MayClinic.com,” Mayo Clinic Staff, Sep. 14, 2007 [Online] [Retrieved on Nov. 14, 2007] Retrieved from the Internet<URL:http://www.mayoclinic.com/health/hepatitis-c/DS00097/DSECTION=8>.
Newman, A.W. et al., “Solid-State Analysis of the Active Pharmaceutical Ingredient in Drug Products,” DDT, Oct. 2003, pp. 898-905, vol. 8, No. 19.
PCT International Search Report, PCT/US2006/005236, Feb. 12, 2007, 1 page.
PCT International Search Report and Written Opinion, PCT/US07/22055, Sep. 12, 2008, 7 pages.
Cao Jie
Cho Hyun-Joon
Fathi Reza
Lam Angela
Li Guolin
Fenwick & West LLP
Rodriguez-Garcia Valerie
Saeed Kamal A
XTL Biopharmaceuticals Ltd.
LandOfFree
4-ethynyl pyrazole derivative compounds and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-ethynyl pyrazole derivative compounds and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-ethynyl pyrazole derivative compounds and methods for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2635017